Service Corporation International Receives ‘Great Place to Work®’ Certification
Mar 07, 2018 21:06 pm UTC| Business
HOUSTON, March 07, 2018 -- Service Corporation International (NYSE:SCI), North America’s largest provider of funeral and cemetery services, announced today it has been certified as a great workplace by the independent...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Mar 07, 2018 21:06 pm UTC| Business
TUSTIN, Calif., March 07, 2018 -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality...
Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates
Mar 07, 2018 21:06 pm UTC| Business
SAN DIEGO, March 07, 2018 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial...
Mar 07, 2018 21:06 pm UTC| Business
ALAMEDA, Calif., March 07, 2018 -- Aqua Metals, Inc. (NASDAQ:AQMS), (“Aqua Metals” or the “Company”), which is proceeding to commercialize its proprietary electrochemical lead recycling technology called AquaRefining™,...
Pacific Ethanol to Sell CO2 From Its Stockton California Plant
Mar 07, 2018 21:05 pm UTC| Business
SACRAMENTO, Calif., March 07, 2018 -- Pacific Ethanol, Inc. (NASDAQ:PEIX), a leading producer and marketer of low-carbon renewable fuels and high-quality alcohol products in the United States, announced its agreement...
Globus Maritime Sets Date for the Release of the Fourth Quarter and Full Year 2017 Results
Mar 07, 2018 21:06 pm UTC| Business
ATHENS, Greece, March 07, 2018 -- Globus Maritime Limited ("Globus," the “Company," “we,” or “our”), (NASDAQ:GLBS), a dry bulk shipping company, announced today that it will release financial results for the three month...
Mar 07, 2018 21:05 pm UTC| Business
SANTA MONICA, Calif., March 07, 2018 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, following the recent approval by...